# Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

> **NCT03865732** · PHASE2 · COMPLETED · sponsor: **Marinus Pharmaceuticals** · enrollment: 29 (actual)

## Conditions studied

- PCDH19-Related Epilepsy

## Interventions

- **DRUG:** Ganaxolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03865732
- **Lead sponsor:** Marinus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-17
- **Primary completion:** 2021-01-19
- **Final completion:** 2022-06-20
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2023-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03865732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03865732, "Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03865732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*